The chances for an offer are low as the offeror would face several hurdles. Nevertheless, the upcoming CARVYKTI commercial production in 2H24 will support the share price without an offer.
What is covered in the Full Insight:
Legend Biotech Takeover Rumors
Shareholder Responses and Market Reaction
Potential Offer and Shareholder Structure
Challenges to Takeover Offer
Conclusion and Future Outlook
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.